Kunming Longjin Pharmaceutical (002750.SZ) has a risk of being delisted after experiencing a four consecutive trading halt.

11/02/2025

GMT Eight

Kunming Longjin Pharmaceutical (002750.SZ) announced that the company has disclosed its performance forecast for 2024, and it is expected that the relevant indicators will meet the conditions stipulated in Article 9.3.12 of the Stock Listing Rules. If the audited financial data in the 2024 annual report ultimately matches the performance forecast data, the company's stock will be delisted from the Shenzhen Stock Exchange.

In the wave of AI, Meta's stock price has risen for 16 consecutive days. Will it become a new member of the 2 trillion dollar club?

YUM CHINA (09987) spent 2.4 million dollars to repurchase 49,800 shares on February 10th.

Contact: contact@gmteight.com

Kunming Longjin Pharmaceutical (002750.SZ) has a risk of being delisted after experiencing a four consecutive trading halt.

RECOMMEND

US Stock Market Move | Elliott, a radical investor, plans to drive operational changes to boost the stock price of Phillips 66 (PSX.US), which has surged nearly 4% against the trend.

Cleveland Fed President Hamaek: The Fed may need to maintain interest rates stable for a longer period of time.

Coolpad Group (02369) released its 2024 interim results, with a net loss attributable to shareholders of HK$90.221 million, a decrease of 23% year-on-year.